Roche, AbbVie leukemia drug superior to older medicine in study Ruby Khatun Khatun24 Nov 2017 9:45 AM ISTPatients with a type of leukemia that had relapsed who received the new drug Venclexta in combination with Rituxan went significantly longer without...
Roche win boosts case for adding chemo to cancer immunotherapy Ruby Khatun Khatun23 Nov 2017 9:30 AM ISTLONDON: Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them...
Roche sues Pfizer to bar biosimilar of cancer drug Herceptin Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTRoche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
FDA backs Roche Gazyva in first-line follicular lymphoma Ruby Khatun Khatun20 Nov 2017 9:30 AM ISTZURICH: The U.S. Food and Drug Administration on Thursday expanded approvals for Roche's Gazyva to include previously untreated follicular lymphoma,...
Roche appoints Lara Bezerra as Roche Pharma India MD Ruby Khatun Khatun17 Nov 2017 10:15 AM ISTNew Delhi: Drug major Roche announced the appointment of Lara Bezerra as Managing Director for Roche Products India.She succeeds Maturin Tchoumi who...
Novartis posts eye drug data amid play for Eylea's turf Ruby Khatun Khatun14 Nov 2017 9:45 AM ISTZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
Roche MS drug Ocrevus wins European panel backing Ruby Khatun Khatun13 Nov 2017 10:02 AM ISTZURICH: Swiss drugmaker Roche on Friday won a key European panel's recommendation for its multiple sclerosis drug Ocrevus, which is on track for...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sept 2017 10:17 AM ISTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
Novartis posts a win, Roche a flop in skin cancer trials Ruby Khatun Khatun12 Sept 2017 12:30 PM ISTZURICH/MADRID: Swiss drugmaker Novartis notched a trial win for its drug cocktail against skin cancer on Monday, while a rival treatment from Roche...
Roche eye drug fails late-stage trial in blow to pipeline Ruby Khatun Khatun11 Sept 2017 9:32 AM ISTZURICH: A drug Roche had hoped would prevent loss of vision and become a big seller failed a late-stage trial, leading some analysts to say on Friday...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 12:25 PM ISTLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...
